May 29 (Reuters) - Catalent ( CTLT ) said on Wednesday
its stockholders have voted to approve its deal with Novo
Holdings, the parent company of Novo Nordisk.
In February, Novo Holdings had agreed to buy Catalent ( CTLT ) for
$16.5 billion.